Brain 17 Vienna

Previous Page

Next Page

Page Background

EORTC 26101

A Phase III Trial Exploring the Combination of

Bevacizumab and Lomustine in Patients with First

Recurrence of a Glioblastoma

Wolfgang Wick

on behalf of the EORTC Brain Tumor Group

Investigators